SPERA PHARMA Inc. (SPERA MEDICAL)
Company Snapshot
Company Overview
Spera Medical develops a range of cardiac diagnostic tests using NGS and other technologies. Spera Medical offers whole-genome sequencing services through its Spera Genomics Division.
Spera Genomics offers a preventive whole-genome sequencing service. The patient’s DNA from blood samples is sequenced at a laboratory at McGill University’s Genome Quebec Innovation Center in Montreal. Genetic counseling is provided if a pathogenic variant is detected.
The main benefit of this preventive test is that it finds variants of which the patient may not be aware, including rare diseases, but that are clinically actionable. The initial focus of the test is the diagnosis of disease, and future expansions of the test may include pharmacogenomic, disease carrier status, nutrigenomics and/or ancestry information.
SPERA PHARMA Inc. (SPERA MEDICAL) In Reports
SPERA PHARMA Inc. (SPERA MEDICAL) In News
Company's Business Segments
- Pharmaceuticals Contract R&D and Manufacturing : The company provides one-stop services of CMC-related works from the early development stage through new drug applications.
Applications/End User Industries
- Pharmaceutical
- Life Sciences